{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:24:02Z","timestamp":1792794242371,"version":"4.5.0"},"reference-count":153,"publisher":"Elsevier","isbn-type":[{"value":"9780443188800","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.apha.2023.04.004","type":"book-chapter","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T20:29:02Z","timestamp":1683145742000},"page":"145-178","source":"Crossref","is-referenced-by-count":9,"title":["Progress in the development of kinase inhibitors for treating asthma and COPD"],"prefix":"10.1016","author":[{"given":"Nathaniel","family":"McClean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery D.","family":"Hasday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apha.2023.04.004_bib1","first-page":"PA549","article-title":"The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells","volume":"58","author":"Adcock","year":"2021","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1378\/chest.08-0440","article-title":"Molecular mechanisms of corticosteroid resistance","volume":"134","author":"Adcock","year":"2008","journal-title":"Chest"},{"key":"10.1016\/bs.apha.2023.04.004_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-042220-015902","article-title":"The pathology of asthma: What is obstructing our view?","volume":"18","author":"Aegerter","year":"2022","journal-title":"Annual Review of Pathology"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2222.2010.03658.x","article-title":"Mitogen-activated protein kinase signalling and ERK1\/2 bistability in asthma","volume":"41","author":"Alam","year":"2011","journal-title":"Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2023.04.004_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000236985","article-title":"The interleukin-5\/receptor interaction activates Lyn and Jak2 tyrosine kinases and propagates signals via the Ras-Raf-1-MAP kinase and the Jak-STAT pathways in eosinophils","volume":"107","author":"Alam","year":"1995","journal-title":"International Archives of Allergy and Immunology"},{"issue":"9","key":"10.1016\/bs.apha.2023.04.004_bib6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/ni.1644","article-title":"The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling","volume":"9","author":"Ananieva","year":"2008","journal-title":"Nature Immunology"},{"issue":"4","key":"10.1016\/bs.apha.2023.04.004_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11040240","article-title":"Systems approaches to treatment response to imatinib in severe asthma: A pilot study","volume":"11","author":"Baek","year":"2021","journal-title":"Journal of Personalized Medicine"},{"issue":"9","key":"10.1016\/bs.apha.2023.04.004_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/labinvest.3700456","article-title":"Transcription factors in airway diseases","volume":"86","author":"Barnes","year":"2006","journal-title":"Laboratory Investigation; A Journal of Technical Methods and Pathology"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/pr.116.012518","article-title":"Kinases as novel therapeutic targets in asthma and chronic obstructive pulmonary disease","volume":"68","author":"Barnes","year":"2016","journal-title":"Pharmacological Reviews"},{"issue":"7","key":"10.1016\/bs.apha.2023.04.004_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/all.13760","article-title":"Inflammatory endotypes in COPD","volume":"74","author":"Barnes","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/bs.apha.2023.04.004_bib11","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2147\/COPD.S309303","article-title":"Exploring PI3Kdelta molecular pathways in stable COPD and following an acute exacerbation, two randomized controlled trials","volume":"16","author":"Begg","year":"2021","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/jpet.118.255109","article-title":"Relationship between pharmacokinetics and pharmacodynamic responses in healthy smokers informs a once-daily dosing regimen for nemiralisib","volume":"369","author":"Begg","year":"2019","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1183\/09031936.06.00012106","article-title":"c-Jun N-terminal kinase-dependent mechanisms in respiratory disease","volume":"28","author":"Bennett","year":"2006","journal-title":"The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology"},{"issue":"4","key":"10.1016\/bs.apha.2023.04.004_bib14","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00071309","article-title":"Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma","volume":"35","author":"Bhavsar","year":"2010","journal-title":"The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9440(10)64867-5","article-title":"Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma","volume":"160","author":"Blease","year":"2002","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaci.2021.02.042","article-title":"Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial","volume":"148","author":"Braithwaite","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcp.21450","article-title":"Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: Differences in asthma","volume":"216","author":"Burgess","year":"2008","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.apha.2023.04.004_bib19","first-page":"1","article-title":"Beyond PI3Ks: Targeting phosphoinositide kinases in disease","author":"Burke","year":"2022","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"16","key":"10.1016\/bs.apha.2023.04.004_bib20","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1073\/pnas.88.16.7410","article-title":"Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases","volume":"88","author":"Burkhardt","year":"1991","journal-title":"Proceeding of the National Academy of Sciences of the United States of\u00a0America"},{"issue":"8","key":"10.1016\/bs.apha.2023.04.004_bib21","first-page":"4183","article-title":"Atypical p38 signaling, activation, and implications for disease","volume":"22","author":"Burton","year":"2021","journal-title":"International Journal of Molecular\u00a0Sciences"},{"issue":"20","key":"10.1016\/bs.apha.2023.04.004_bib22","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1613125","article-title":"KIT inhibition by imatinib in patients with severe refractory asthma","volume":"376","author":"Cahill","year":"2017","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.apha.2023.04.004_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pupt.2017.08.008","article-title":"Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kdelta inhibitor under development for the treatment of COPD","volume":"46","author":"Cahn","year":"2017","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib24","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1038\/s41467-018-07698-6","article-title":"Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis","volume":"9","author":"Campa","year":"2018","journal-title":"Nature Communications"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2023.04.004_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/15419061.2013.775257","article-title":"Role of transcription factors in the pathogenesis of asthma and COPD","volume":"20","author":"Caramori","year":"2013","journal-title":"Cell Communication & Adhesion"},{"key":"10.1016\/bs.apha.2023.04.004_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2019.05.006","article-title":"Transcription inhibitors and inflammatory cell activity","volume":"46","author":"Caramori","year":"2019","journal-title":"Current Opinion in Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2023.04.004_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00188-2017","article-title":"RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-alpha and -gamma selectivity, suppresses COPD inflammation","volume":"50","author":"Charron","year":"2017","journal-title":"The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology"},{"issue":"12","key":"10.1016\/bs.apha.2023.04.004_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144689","article-title":"RIP3-dependent necroptosis contributes to the pathogenesis of chronic obstructive pulmonary disease","volume":"6","author":"Chen","year":"2021","journal-title":"JCI Insight"},{"issue":"10342","key":"10.1016\/bs.apha.2023.04.004_bib29","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6","article-title":"Chronic obstructive pulmonary disease","volume":"399","author":"Christenson","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/bs.apha.2023.04.004_bib30","doi-asserted-by":"crossref","first-page":"50s","DOI":"10.1183\/09031936.01.00229701","article-title":"Cytokines in chronic obstructive pulmonary disease","volume":"34","author":"Chung","year":"2001","journal-title":"The European Respiratory Journal. Supplement"},{"issue":"6","key":"10.1016\/bs.apha.2023.04.004_bib31","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1378\/chest.10-1914","article-title":"p38 mitogen-activated protein kinase pathways in asthma and COPD","volume":"139","author":"Chung","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.200607-1062OC","article-title":"Epithelial cell proliferation contributes to airway remodeling in severe asthma","volume":"176","author":"Cohen","year":"2007","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib33","doi-asserted-by":"crossref","first-page":"2131751","DOI":"10.1080\/09537104.2022.2131751","article-title":"Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib","volume":"34","author":"Cooper","year":"2023","journal-title":"Platelets"},{"key":"10.1016\/bs.apha.2023.04.004_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100428","article-title":"Salt-inducible kinases are required for the IL-33-dependent secretion of cytokines and chemokines in mast cells","volume":"296","author":"Darling","year":"2021","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.04.004_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/JAA.S337284","article-title":"Efficacy and safety of masitinib in corticosteroid-dependent severe asthma: A randomized placebo-controlled trial","volume":"15","author":"Davidescu","year":"2022","journal-title":"Journal of Asthma and Allergy"},{"issue":"16","key":"10.1016\/bs.apha.2023.04.004_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121144","article-title":"The TAB1-p38alpha complex aggravates myocardial injury and can be targeted by small molecules","volume":"3","author":"De Nicola","year":"2018","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/bs.apha.2023.04.004_bib37","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1096\/fj.201900680R","article-title":"Effects of ATP-competitive and function-selective ERK inhibitors on airway smooth muscle cell proliferation","volume":"33","author":"Defnet","year":"2019","journal-title":"The FASEB Journal"},{"issue":"12","key":"10.1016\/bs.apha.2023.04.004_bib38","first-page":"CD013432","article-title":"Anti-IL-5 therapies for chronic obstructive pulmonary disease","volume":"12","author":"Donovan","year":"2020","journal-title":"Cochrane Database of Systematic Reviews (Online)"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2023.04.004_bib40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2174\/138945006777435353","article-title":"Targeting mitogen-activated protein kinases for asthma","volume":"7","author":"Duan","year":"2006","journal-title":"Current Drug Targets"},{"issue":"9","key":"10.1016\/bs.apha.2023.04.004_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007258","article-title":"Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT","volume":"4","author":"Dubreuil","year":"2009","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/bs.apha.2023.04.004_bib42","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1042\/CS20180398","article-title":"Apoptosis signal-regulating kinase 1 inhibition attenuates human airway smooth muscle growth and migration in chronic obstructive pulmonary disease","volume":"132","author":"Eapen","year":"2018","journal-title":"Clinical science\u00a0(London)"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib43","first-page":"1194","article-title":"Long-term therapy response to anti-IL-5 biologics in severe asthma\u2014A real-life evaluation","volume":"9","author":"Eger","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1083\/jcb.201401050","article-title":"The cell biology of asthma","volume":"205","author":"Erle","year":"2014","journal-title":"The Journal of Cell Biology"},{"issue":"21","key":"10.1016\/bs.apha.2023.04.004_bib45","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1021\/acs.jmedchem.8b00873","article-title":"Discovery of a novel inhaled PI3Kdelta inhibitor for the treatment of respiratory diseases","volume":"61","author":"Erra","year":"2018","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2023.04.004_bib46","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2147\/COPD.S309320","article-title":"Nemiralisib in patients with an acute exacerbation of COPD: Placebo-controlled, dose-ranging study","volume":"16","author":"Fahy","year":"2021","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib47","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00441-016-2566-8","article-title":"Airway remodeling in asthma: What really matters","volume":"367","author":"Fehrenbach","year":"2017","journal-title":"Cell and Tissue Research"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1753465807080740","article-title":"Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease","volume":"1","author":"Fernandes","year":"2007","journal-title":"Therapeutic Advances in Respiratory Disease"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/1541-7786.MCR-11-0507","article-title":"TGF-beta1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38beta to proapoptotic p38alpha","volume":"10","author":"Ferrari","year":"2012","journal-title":"Molecular Cancer Research: MCR"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194197","article-title":"The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial","volume":"13","author":"Fisk","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2023.04.004_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175450","article-title":"The anti-asthmatic potential of Rho-kinase inhibitor hydroxyfasudil in the model of experimentally induced allergic airway inflammation","volume":"938","author":"Franova","year":"2023","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13075-022-02850-6","article-title":"CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production","volume":"24","author":"Gaur","year":"2022","journal-title":"Arthritis Research & Therapy"},{"issue":"5558","key":"10.1016\/bs.apha.2023.04.004_bib53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.1067289","article-title":"MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha","volume":"295","author":"Ge","year":"2002","journal-title":"Science (New York, N. Y.)"},{"issue":"4","key":"10.1016\/bs.apha.2023.04.004_bib54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jaci.2021.08.013","article-title":"JAK inhibitors for asthma","volume":"148","author":"Georas","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1165\/rcmb.2013-0258OC","article-title":"Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction","volume":"50","author":"Geraghty","year":"2014","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/bs.apha.2023.04.004_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.839011","article-title":"Omalizumab and IgE in the control of severe allergic asthma","volume":"13","author":"Gon","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"29","key":"10.1016\/bs.apha.2023.04.004_bib57","article-title":"MK2 degradation as a sensor of signal intensity that controls stress-induced cell fate","volume":"118","author":"Gutierrez-Prat","year":"2021","journal-title":"Proceeding of the National Academy of Sciences of the United States of\u00a0America"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.coph.2010.06.004","article-title":"Airway remodeling in asthma","volume":"10","author":"Halwani","year":"2010","journal-title":"Current Opinion in Pharmacology"},{"issue":"14","key":"10.1016\/bs.apha.2023.04.004_bib59","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1021\/jm0501174","article-title":"Identification of novel extracellular signal-regulated kinase docking domain inhibitors","volume":"48","author":"Hancock","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2023.04.004_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108153","article-title":"Targeting the p38alpha pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?","volume":"235","author":"Heng","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1432-1033.2004.04404.x","article-title":"Principles behind the multifarious control of signal transduction. ERK phosphorylation and kinase\/phosphatase control","volume":"272","author":"Hornberg","year":"2005","journal-title":"The FEBS Journal"},{"key":"10.1016\/bs.apha.2023.04.004_bib62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fmed.2020.00191","article-title":"Airway remodeling in asthma","volume":"7","author":"Hough","year":"2020","journal-title":"Frontiers in Medicine (Lausanne)"},{"issue":"8","key":"10.1016\/bs.apha.2023.04.004_bib63","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1398-9995.2009.02122.x","article-title":"Masitinib, a c-kit\/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics","volume":"64","author":"Humbert","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/bs.apha.2023.04.004_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/357027","article-title":"Imatinib: a breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Chemotherapy Research and Practice"},{"issue":"5600","key":"10.1016\/bs.apha.2023.04.004_bib65","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science (New York, N. Y.)"},{"issue":"6989","key":"10.1016\/bs.apha.2023.04.004_bib66","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","article-title":"Community study of role of viral infections in exacerbations of asthma in 9-11 year old children","volume":"310","author":"Johnston","year":"1995","journal-title":"BMJ (Clinical Research ed.)"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib67","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1164\/ajrccm.164.5.2012125","article-title":"The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control","volume":"164","author":"Jones","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/bs.apha.2023.04.004_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2021.656886","article-title":"G Protein-coupled receptor kinase 2 (GRK2) regulates T cell response in a murine model of house dust mite-induced asthma","volume":"2","author":"Kammala","year":"2021","journal-title":"Frontiers in Allergy"},{"key":"10.1016\/bs.apha.2023.04.004_bib69","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphar.2019.00897","article-title":"Efficacy and safety of multiple dosages of fostamatinib in adult patients with rheumatoid arthritis: A systematic review and meta-analysis","volume":"10","author":"Kang","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2023.04.004_bib70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fphar.2020.00047","article-title":"Role of platelet-derived growth factor (PDGF) in asthma as an immunoregulatory factor mediating airway remodeling and possible pharmacological target","volume":"11","author":"Kardas","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"28","key":"10.1016\/bs.apha.2023.04.004_bib71","doi-asserted-by":"crossref","first-page":"16483","DOI":"10.1074\/jbc.270.28.16483","article-title":"The regulation of AP-1 activity by mitogen-activated protein kinases","volume":"270","author":"Karin","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/jpet.118.249516","article-title":"A multicentre, randomized, double-blind, placebo-controlled, crossover study to investigate the efficacy, safety, tolerability, and pharmacokinetics of repeat doses of inhaled nemiralisib in adults with persistent, uncontrolled asthma","volume":"367","author":"Khindri","year":"2018","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"9","key":"10.1016\/bs.apha.2023.04.004_bib73","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/ni.1640","article-title":"The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression","volume":"9","author":"Kim","year":"2008","journal-title":"Nature Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib74","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jaci.2017.09.026","article-title":"Superior anti-inflammatory effects of narrow-spectrum kinase inhibitors in airway smooth muscle cells from subjects with chronic obstructive pulmonary disease","volume":"141","author":"Knobloch","year":"2018","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1016\/bs.apha.2023.04.004_bib75","doi-asserted-by":"crossref","first-page":"L1068","DOI":"10.1152\/ajplung.00025.2008","article-title":"Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium","volume":"294","author":"Koff","year":"2008","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"6","key":"10.1016\/bs.apha.2023.04.004_bib76","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.187.6.939","article-title":"Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production","volume":"187","author":"Kuperman","year":"1998","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.apha.2023.04.004_bib77","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2147\/COPD.S211619","article-title":"Dual role for a MEK inhibitor as a modulator of inflammation and host defense mechanisms with potential therapeutic application in COPD","volume":"14","author":"Kurian","year":"2019","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"10.1016\/bs.apha.2023.04.004_bib79","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2147\/COPD.S121416","article-title":"Emerging pharmaceutical therapies for COPD","volume":"12","author":"Lakshmi","year":"2017","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib80","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00109-020-01873-3","article-title":"P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells","volume":"98","author":"Lea","year":"2020","journal-title":"The\u00a0Journal of Molecular Medicine (Berl)"},{"issue":"6508","key":"10.1016\/bs.apha.2023.04.004_bib81","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","article-title":"A protein kinase involved in the regulation of inflammatory cytokine biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib82","doi-asserted-by":"crossref","first-page":"L1019","DOI":"10.1152\/ajplung.2001.280.5.L1019","article-title":"ERK activation and mitogenesis in human airway smooth muscle cells","volume":"280","author":"Lee","year":"2001","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"4","key":"10.1016\/bs.apha.2023.04.004_bib83","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jaci.2008.02.004","article-title":"Cell-specific activation profile of extracellular signal-regulated kinase 1\/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways","volume":"121","author":"Liu","year":"2008","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib84","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s10753-021-01466-3","article-title":"PI3K\/AKT\/mTOR and TLR4\/MyD88\/NF-kappaB signaling inhibitors attenuate pathological mechanisms of allergic asthma","volume":"44","author":"Ma","year":"2021","journal-title":"Inflammation"},{"issue":"8","key":"10.1016\/bs.apha.2023.04.004_bib85","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/thoraxjnl-2012-202744","article-title":"Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: A randomised clinical trial","volume":"68","author":"MacNee","year":"2013","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/bs.apha.2023.04.004_bib86","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2021.08.020","article-title":"The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in mice","volume":"149","author":"Maes","year":"2022","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/bs.apha.2023.04.004_bib87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trsl.2022.06.005","article-title":"Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders","volume":"249","author":"Malona","year":"2022","journal-title":"Translational Research: The Journal of Laboratory and Clinical Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib88","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.ddmec.2010.07.006","article-title":"Developing small molecules to inhibit kinases unkind to the heart: p38 MAPK as a case in point","volume":"7","author":"Marber","year":"2010","journal-title":"Drug Discovery Today. Disease Mechanisms"},{"issue":"7","key":"10.1016\/bs.apha.2023.04.004_bib89","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/rccm.200810-1570OC","article-title":"Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice","volume":"179","author":"Marwick","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1016\/bs.apha.2023.04.004_bib90","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s40262-022-01135-0","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406","volume":"61","author":"Matsukane","year":"2022","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/bs.apha.2023.04.004_bib91","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.coph.2019.04.010","article-title":"Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD","volume":"46","author":"Mei","year":"2019","journal-title":"Current Opinion in Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib92","first-page":"137","article-title":"Emerging role of MAP kinase pathways as therapeutic targets in COPD","volume":"1","author":"Mercer","year":"2006","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib93","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1038\/s41598-022-09241-6","article-title":"The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma and COPD patients in vitro","volume":"12","author":"Milara","year":"2022","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/bs.apha.2023.04.004_bib94","article-title":"Fractional exhaled nitric oxide testing: Diagnostic utility in asthma, chronic obstructive pulmonary disease, or asthma-chronic obstructive pulmonary disease overlap syndrome","volume":"11","author":"Miskoff","year":"2019","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/bs.apha.2023.04.004_bib95","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1172\/JCI74985","article-title":"Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD","volume":"124","author":"Mizumura","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/bs.apha.2023.04.004_bib96","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: A crucial player in diverse biological functions","volume":"10","author":"Mocsai","year":"2010","journal-title":"Nature Reviews. Immunology"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib97","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1124\/jpet.110.173583","article-title":"Phosphatidylinositol 3-kinase isoform-specific effects in airway mesenchymal cell function","volume":"337","author":"Moir","year":"2011","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib98","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/path.5696","article-title":"PI3K signalling in chronic obstructive pulmonary disease and opportunities for therapy","volume":"254","author":"Moradi","year":"2021","journal-title":"The Journal of Pathology"},{"issue":"10","key":"10.1016\/bs.apha.2023.04.004_bib99","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/s12276-022-00868-z","article-title":"Roles of RIPK3 in necroptosis, cell signaling, and disease","volume":"54","author":"Morgan","year":"2022","journal-title":"Experimental & Molecular Medicine"},{"issue":"10","key":"10.1016\/bs.apha.2023.04.004_bib100","first-page":"L1112","article-title":"Glycogen synthase kinase-3beta modulation of glucocorticoid responsiveness in COPD","volume":"309","author":"Ngkelo","year":"2015","journal-title":"American Journal of"},{"issue":"43","key":"10.1016\/bs.apha.2023.04.004_bib101","first-page":"E9163","article-title":"beta(2)-Adrenoceptor signaling in airway epithelial cells promotes eosinophilic inflammation, mucous metaplasia, and airway contractility","volume":"114","author":"Nguyen","year":"2017","journal-title":"Proceeding of the National Academy of Sciences of the United States of\u00a0America"},{"key":"10.1016\/bs.apha.2023.04.004_bib102","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2147\/DDDT.S354291","article-title":"Characterization of selective and potent JAK1 inhibitors intended for the inhaled treatment of asthma","volume":"16","author":"Nilsson","year":"2022","journal-title":"Drug Design, Development and Therapy"},{"issue":"48","key":"10.1016\/bs.apha.2023.04.004_bib103","doi-asserted-by":"crossref","first-page":"34663","DOI":"10.1074\/jbc.M704236200","article-title":"Chemical genetics define the roles of p38alpha and p38beta in acute and chronic inflammation","volume":"282","author":"O\u2019Keefe","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.04.004_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.687654","article-title":"Airway epithelial cells drive airway smooth muscle cell phenotype switching to the proliferative and pro-inflammatory phenotype","volume":"12","author":"O\u2019Sullivan","year":"2021","journal-title":"Frontiers in Physiology"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib105","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41385-021-00415-5","article-title":"Airway epithelial cell necroptosis contributes to asthma exacerbation in a mouse model of house dust mite-induced allergic inflammation","volume":"14","author":"Oikonomou","year":"2021","journal-title":"Mucosal Immunology"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib106","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.apsb.2021.12.022","article-title":"Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy","volume":"12","author":"Pan","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib107","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.05.028","article-title":"Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun N-terminal kinase activation","volume":"132","author":"Papi","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/bs.apha.2023.04.004_bib108","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.rmed.2017.07.002","article-title":"Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD","volume":"130","author":"Pascoe","year":"2017","journal-title":"Respiratory Medicine"},{"key":"10.1016\/bs.apha.2023.04.004_bib109","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2147\/COPD.S150576","article-title":"The development of AZD7624 for prevention of exacerbations in COPD: A randomized controlled trial","volume":"13","author":"Patel","year":"2018","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/17476348.2020.1732821","article-title":"Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives","volume":"14","author":"Pelaia","year":"2020","journal-title":"Expert Review of Respiratory Medicine"},{"issue":"22","key":"10.1016\/bs.apha.2023.04.004_bib111","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1007\/s00018-019-03274-3","article-title":"G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub","volume":"76","author":"Penela","year":"2019","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"issue":"10","key":"10.1016\/bs.apha.2023.04.004_bib112","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1172\/JCI0215786","article-title":"JAK-STAT signaling in asthma","volume":"109","author":"Pernis","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/bs.apha.2023.04.004_bib113","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1021\/acs.jmedchem.1c00434","article-title":"Discovery of AZD8154, a dual PI3Kgammadelta inhibitor for the treatment of asthma","volume":"64","author":"Perry","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2023.04.004_bib114","first-page":"OA1195","article-title":"Safety, pharmacokinetics, and pharmacodynamics of TD-8236, an inhaled pan-JAK inhibitor, following single- and multiple-ascending doses in healthy volunteers and mild asthmatics","volume":"58","author":"Pfeifer","year":"2021","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1183\/09031936.02.01132002","article-title":"Adenosine-receptor subtypes: Their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease","volume":"20","author":"Polosa","year":"2002","journal-title":"The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology"},{"issue":"10","key":"10.1016\/bs.apha.2023.04.004_bib116","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tips.2009.07.005","article-title":"Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease","volume":"30","author":"Polosa","year":"2009","journal-title":"Trends in Pharmacological Sciences"},{"issue":"10","key":"10.1016\/bs.apha.2023.04.004_bib117","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1096\/fasebj.14.10.1362","article-title":"Involvement of the epidermal growth factor receptor in epithelial repair in asthma","volume":"14","author":"Puddicombe","year":"2000","journal-title":"The FASEB Journal"},{"issue":"4","key":"10.1016\/bs.apha.2023.04.004_bib118","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acschemneuro.5b00002","article-title":"Targeting human central nervous system protein kinases: An isoform selective p38alphaMAPK inhibitor that attenuates disease progression in Alzheimer\u2019s disease mouse models","volume":"6","author":"Roy","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.apha.2023.04.004_bib119","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fcell.2016.00067","article-title":"Redundancy in the world of MAP kinases: All for one","volume":"4","author":"Saba-El-Leil","year":"2016","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bcp.14956","article-title":"Characterisation of pharmacokinetics, safety and tolerability in a first-in-human study for AZD8154, a novel inhaled selective PI3Kgammadelta dual inhibitor targeting airway inflammatory disease","volume":"88","author":"Sadiq","year":"2022","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib121","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/BJ20131571","article-title":"Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf","volume":"467","author":"Samadani","year":"2015","journal-title":"The Biochemical Journal"},{"issue":"9","key":"10.1016\/bs.apha.2023.04.004_bib122","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease","volume":"164","author":"Seemungal","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"8","key":"10.1016\/bs.apha.2023.04.004_bib123","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.4049\/jimmunol.1602059","article-title":"Novel noncatalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity","volume":"198","author":"Shah","year":"2017","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib124","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1165\/rcmb.2022-0110OC","article-title":"Targeted inhibition of select ERK1\/2 functions mitigates pathological features of asthma in mice","volume":"68","author":"Shah","year":"2022","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"10","key":"10.1016\/bs.apha.2023.04.004_bib125","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00228-015-1920-1","article-title":"Oral and inhaled p38 MAPK inhibitors: Effects on inhaled LPS challenge in healthy subjects","volume":"71","author":"Singh","year":"2015","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib126","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0091270009347873","article-title":"A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients","volume":"50","author":"Singh","year":"2010","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/bs.apha.2023.04.004_bib127","first-page":"14","article-title":"PI3K, p38 and JAK\/STAT signalling in bronchial tissue from patients with asthma following allergen challenge","volume":"6","author":"Southworth","year":"2018","journal-title":"Biomarker\u00a0Research"},{"issue":"7","key":"10.1016\/bs.apha.2023.04.004_bib128","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1128\/AAC.00303-13","article-title":"Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo","volume":"57","author":"Spickler","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5\u20136","key":"10.1016\/bs.apha.2023.04.004_bib129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/15412555.2019.1682535","article-title":"Phase II study of single\/repeated doses of acumapimod (BCT197) to treat acute exacerbations of COPD","volume":"16","author":"Strambu","year":"2019","journal-title":"COPD"},{"key":"10.1016\/bs.apha.2023.04.004_bib130","doi-asserted-by":"crossref","unstructured":"Streiler, C., Jasahui, M. P.,\u00a0Nazir, U., Jandali, M. B., Lovell, K., Fruhauf, E., \u2026 Gan, G. (2022). A trial of MK2 inhibitor ATI-450 in patients with moderate-severe novel coronavirus disease 2019 (COVID-19). ATS International Conference abstract, B57.","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A3134"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib131","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1093\/cid\/ciab732","article-title":"Fostamatinib for the treatment of hospitalized adults with coronavirus disease 2019: A randomized trial","volume":"75","author":"Strich","year":"2022","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"6","key":"10.1016\/bs.apha.2023.04.004_bib132","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1165\/rcmb.2020-0520OC","article-title":"HDAC6 activates ERK in airway and pulmonary vascular remodeling of chronic obstructive pulmonary disease","volume":"65","author":"Su","year":"2021","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib133","first-page":"150","article-title":"The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis","volume":"5","author":"Sun","year":"2020","journal-title":"Signal Transduction\u00a0and\u00a0Targeted\u00a0Therapy"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib134","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/resp.12653","article-title":"Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge","volume":"21","author":"Tho","year":"2016","journal-title":"Respirology (Carlton, Vic.)"},{"issue":"4","key":"10.1016\/bs.apha.2023.04.004_bib135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000375168","article-title":"Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium","volume":"89","author":"Vallese","year":"2015","journal-title":"Respiration; International Review of Thoracic Diseases"},{"issue":"49","key":"10.1016\/bs.apha.2023.04.004_bib136","doi-asserted-by":"crossref","first-page":"31331","DOI":"10.1073\/pnas.2009847117","article-title":"TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells","volume":"117","author":"Vanderkerken","year":"2020","journal-title":"Proceeding of the National Academy of Sciences of the United States of\u00a0America"},{"issue":"153","key":"10.1016\/bs.apha.2023.04.004_bib137","article-title":"Cellular mechanisms underlying steroid-resistant asthma","volume":"28","author":"Wadhwa","year":"2019","journal-title":"The European\u00a0Respiratory Review"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib138","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.20172063","article-title":"Selective inhibition of the p38alpha MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals","volume":"215","author":"Wang","year":"2018","journal-title":"The Journal of Experimental Medicine"},{"issue":"10","key":"10.1016\/bs.apha.2023.04.004_bib139","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/aps.2015.71","article-title":"PI3K isoform-selective inhibitors: next-generation targeted cancer therapies","volume":"36","author":"Wang","year":"2015","journal-title":"Acta Pharmacologica Sinica"},{"issue":"8","key":"10.1016\/bs.apha.2023.04.004_bib140","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.clinthera.2018.06.011","article-title":"Safety, tolerability, and pharmacokinetics of single and repeat doses of nemiralisib administered via the ellipta dry powder inhaler to healthy subjects","volume":"40","author":"Wilson","year":"2018","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1016\/bs.apha.2023.04.004_bib141","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.clinthera.2019.04.008","article-title":"Safety, tolerability, and pharmacokinetics of a new formulation of nemiralisib administered via a dry powder inhaler to healthyindividuals","volume":"41","author":"Wilson","year":"2019","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1016\/bs.apha.2023.04.004_bib142","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coph.2005.01.009","article-title":"Inhibitors of the tyrosine kinase signaling cascade for asthma","volume":"5","author":"Wong","year":"2005","journal-title":"Current Opinion in Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2023.04.004_bib143","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1164\/rccm.200909-1415OC","article-title":"Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease","volume":"181","author":"Woodruff","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2 Pt B","key":"10.1016\/bs.apha.2023.04.004_bib144","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molimm.2015.06.016","article-title":"SP600125 promotes resolution of allergic airway inflammation via TLR9 in an OVA-induced murine acute asthma model","volume":"67","author":"Wu","year":"2015","journal-title":"Molecular Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib145","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/14756366.2020.1720013","article-title":"Selective inhibitors for JNK signalling: a potential targeted therapy in cancer","volume":"35","author":"Wu","year":"2020","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2023.04.004_bib146","article-title":"Rho-Kinase 1\/2 inhibition prevents transforming growth factor-beta-induced effects on pulmonary remodeling and repair","volume":"11","author":"Wu","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.04.004_bib147","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1378\/chest.07-3020","article-title":"The possible role of hematopoietic cell kinase in the pathophysiology of COPD","volume":"135","author":"Yanagisawa","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1016\/bs.apha.2023.04.004_bib148","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1165\/rcmb.2016-0308TR","article-title":"Phosphoinositide 3-kinase in asthma: Novel roles and therapeutic approaches","volume":"56","author":"Yoo","year":"2017","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"10","key":"10.1016\/bs.apha.2023.04.004_bib149","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/1087057113497401","article-title":"Perspective on the discovery and scientific impact of p38 MAP kinase","volume":"18","author":"Young","year":"2013","journal-title":"Journal of Biomolecular Screening: The Official Journal of the Society for Biomolecular Screening"},{"key":"10.1016\/bs.apha.2023.04.004_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.992731","article-title":"Dupilumab efficacy and safety in patients with moderate to severe asthma: A systematic review and meta-analysis","volume":"13","author":"Zaazouee","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/bs.apha.2023.04.004_bib151","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbrc.2019.06.072","article-title":"Rho-kinase inhibitor attenuates airway mucus hypersecretion and inflammation partly by downregulation of IL-13 and the JNK1\/2-AP1 signaling pathway","volume":"516","author":"Zhang","year":"2019","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"10.1016\/bs.apha.2023.04.004_bib152","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrclinonc.2014.83","article-title":"The clinical development of MEK inhibitors","volume":"11","author":"Zhao","year":"2014","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2023.04.004_bib153","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1569-9048(03)00154-X","article-title":"Mitogenic signaling pathways in airway smooth muscle","volume":"137","author":"Zhou","year":"2003","journal-title":"Respiratory Physiology & Neurobiology"}],"container-title":["Advances in Pharmacology","Pulmonary Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:48Z","timestamp":1715315508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358923000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443188800"],"references-count":153,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2023.04.004","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}